Hematopoiesis is the main function of the liver during a considerable period of mammalian prenatal development. Hematopoietic cells of the fetal liver exist in a specific microenvironment that controls their proliferation and differentiation. This microenvironment is created by different cell populations, including epitheliocytes, macrophages, various stromal elements (hepatic stellate cells, fibroblasts, myofibroblasts, vascular smooth muscle and endothelial cells, mesenchymal stromal cells), and also cells undergoing epithelial-to-mesenchymal transition. This paper considers the involvement of these cell types in the regulation of fetal liver hematopoiesis. 1. Introduction In mammals, the liver serves as the main hematopoietic organ during a considerable period of prenatal ontogeny. In murine liver, for example, hematopoietic cells first appear in 10-day embryos, with hematopoietic function of the organ reaching a peak on embryonic days 13–14 and ceasing during the first 2–4 postnatal days [1, 2]. Hematopoiesis requires specific microenvironment that produces chemical signals to attract hematopoietic cells and regulates their proliferation and differentiation via contact and humoral interactions. The hematopoietic microenvironment of the fetal liver is created by a complex of cell types, including epitheliocytes, resident macrophages, and several stromal cell populations of mesenchymal origin such as hepatic stellate cells, fibroblasts, myofibroblasts, vascular smooth muscle and endothelial cells, and mesenchymal stromal cells (MSCs). Let us consider the roles of different cell components of this microenvironment in the maintenance of hematopoietic activity in the developing liver. 2. Liver Epithelium At early stages of liver development, its epithelium is represented by bipotent hepatoblasts, which subsequently differentiate into hepatocytes and cholangiocytes [1, 2]. Hepatoblasts can be identified by the simultaneous expression of both hepatic (cytokeratin 18, albumin) and biliary epithelial markers (cytokeratin 19) and also of E-cadherin [3]. The morphology and phenotype of liver epithelial cells change in the course of development, and these changes correlate with hematopoietic activity [4, 5]. Cells of the hepatocyte lineage appear to play an important role in the regulation of erythropoiesis: they closely interact with erythroblasts [5] and produce erythropoietic cytokines such as stem cell factor and erythropoietin [6, 7]. Localization of megakaryocyte lineage cells among hepatocytes described in human fetal liver [8] and thrombopoietin
References
[1]
K. Sasaki and Y. Sonoda, “Histometrical and three-dimensional analyses of liver hematopoiesis in the mouse embryo,” Archives of Histology and Cytology, vol. 63, no. 2, pp. 137–146, 2000.
[2]
Y. Guo, X. Zhang, J. Huang et al., “Relationships between hematopoiesis and hepatogenesis in the midtrimester fetal liver characterized by dynamic transcriptomic and proteomic profiles,” PLoS ONE, vol. 4, no. 10, article e7641s, 2009.
[3]
J. D. Terrace, I. S. Currie, D. C. Hay et al., “Progenitor cell characterization and location in the developing human liver,” Stem Cells and Development, vol. 16, no. 5, pp. 771–778, 2007.
[4]
T. Fukumoto, “Possible developmental interactions of hematopoietic cells and hepatocytes in fetal rat liver,” Biomedical Research, vol. 13, no. 6, pp. 385–413, 1992.
[5]
J. D. P. Ayres-Silva, P. P. D. A. Manso, M. R. D. C. Madeira, M. Pelajo-Machado, and H. L. Lenzi, “Sequential morphological characteristics of murine fetal liver hematopoietic microenvironment in Swiss Webster mice,” Cell and Tissue Research, vol. 344, no. 3, pp. 455–469, 2011.
[6]
K. U. Eckardt, “Erythropoietin production in liver and kidneys,” Current Opinion in Nephrology and Hypertension, vol. 5, pp. 28–34, 1996.
[7]
D. Sugiyama, K. Kulkeaw, C. Mizuochi, Y. Horio, and S. Okayama, “Hepatoblasts comprise a niche for fetal liver erythropoiesis through cytokine production,” Biochemical and Biophysical Research Communications, vol. 410, no. 2, pp. 301–306, 2011.
[8]
I. Emura, M. Sekiya, and Y. Ohnishi, “Ultrastructural identification of the hemopoietic inductive microenvironment in the human embryonic liver,” Archivum Histologicum Japonicum, vol. 47, no. 1, pp. 95–112, 1984.
[9]
A. Aiuti, C. Cicchini, S. Bernardini et al., “Hematopoietic support and cytokine expression of murine-stable hepatocyte cell lines (MMH),” Hepatology, vol. 28, no. 6, pp. 1645–1654, 1998.
[10]
M. Nanno, M. Hata, H. Doi et al., “Stimulation of in vitro hematopoiesis by a murine fetal hepatocyte clone through cell-cell contact,” Journal of Cellular Physiology, vol. 160, no. 3, pp. 445–454, 1994.
[11]
A. Corlu, I. Lamy, G. P. Ilyin et al., “Hematopoiesis-promoting activity of rat liver biliary epithelial cells: Involvement of a cell surface molecule, liver-regulating protein,” Experimental Hematology, vol. 26, no. 5, pp. 382–394, 1998.
[12]
K. Sasaki and H. Iwatsuki, “Origin and fate of the central macrophages of erythroblastic islands in the fetal and neonatal mouse liver,” Microscopy Research and Technique, vol. 39, no. 5, pp. 398–405, 1997.
[13]
D. Li, G. Y. Wang, Z. F. Liu, Y. X. Shi, H. Zhang, and Z. L. Bai, “Macrophage-associated erythropoiesis and lymphocytopoiesis in mouse fetal liver: ultrastructural and ISH analysis,” Cell Biology International, vol. 28, no. 6, pp. 457–461, 2004.
[14]
S. Soni, S. Bala, B. Gwynn, K. E. Sahr, L. L. Peters, and M. Hanspal, “Absence of erythroblast macrophage protein (Emp) leads to failure of erythroblast nuclear extrusion,” Journal of Biological Chemistry, vol. 281, no. 29, pp. 20181–20189, 2006.
[15]
J. Isern, S. T. Fraser, Z. He, and M. H. Baron, “The fetal liver is a niche for maturation of primitive erythroid cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 18, pp. 6662–6667, 2008.
[16]
C. Schulz, E. Gomez Perdiguero, L. Chorro, et al., “A lineage of myeloid cells independent of Myb and hematopoietic stem cells,” Science, vol. 336, pp. 86–90, 2012.
[17]
P. W. Bankston and R. M. Pino, “The development of the sinusoids of fetal rat liver: morphology of endothelial cells, Kupffer cells, and the transmural migration of blood cells into the sinusoids,” American Journal of Anatomy, vol. 159, no. 1, pp. 1–15, 1980.
[18]
W. B. Lee, S. K. Erm, K. Y. Kim, and R. P. Becker, “Emperipolesis of erythroblasts within Kupffer cells during hepatic hemopoiesis in human fetus,” The Anatomical Record, vol. 256, pp. 158–164, 1999.
[19]
P. Paul, S. A. Rothmann, J. T. McMahon, and A. S. Gordon, “Erythropoietin secretion by isolated rat Kupffer cells,” Experimental Hematology, vol. 12, no. 11, pp. 825–830, 1984.
[20]
G. Ramadori and B. Saile, “Mesenchymal cells in the liver—one cell type or two?” Liver, vol. 22, no. 4, pp. 283–294, 2002.
[21]
M. Sato, S. Suzuki, and H. Senoo, “Hepatic stellate cells: unique characteristics in cell biology and phenotype,” Cell Structure and Function, vol. 28, no. 2, pp. 105–112, 2003.
[22]
C. Guyot, S. Lepreux, C. Combe et al., “Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 2, pp. 135–151, 2006.
[23]
A. P. Kiassov, P. Van Eyken, J. F. Van Pelt et al., “Desmin expressing nonhematopoietic liver cells during rat liver development: an immunohistochemical and morphometric study,” Differentiation, vol. 59, no. 4, pp. 253–258, 1995.
[24]
H. Kubota, H. L. Yao, and L. M. Reid, “Identification and characterization of vitamin A-storing cells in fetal liver: implications for functional importance of hepatic stellate cells in liver development and hematopoiesis,” Stem Cells, vol. 25, no. 9, pp. 2339–2349, 2007.
[25]
J. Villeneuve, F. Pelluard-Nehme, C. Combe et al., “Immunohistochemical study of the phenotypic change of the mesenchymal cells during portal tract maturation in normal and fibrous (ductal plate malformation) fetal liver,” Comparative Hepatology, vol. 8, article 5, 2009.
[26]
C. K. C. Loo and X. J. Wu, “Origin of stellate cells from submesothelial cells in a developing human liver,” Liver International, vol. 28, no. 10, pp. 1437–1445, 2008.
[27]
B. Samama and N. Boehm, “Reelin immunoreactivity in lymphatics and liver during development and adult life,” The Anatomical Record A, vol. 285, pp. 595–599, 2005.
[28]
H. Enzan, H. Himeno, M. Hiroi, H. Kiyoku, T. Saibara, and S. Onishi, “Development of hepatic sinusoidal structure with special reference to the Ito cells,” Microscopy Research and Technique, vol. 39, pp. 336–349, 1997.
[29]
K. Asahina, S. Y. Tsai, P. Li et al., “Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development,” Hepatology, vol. 49, no. 3, pp. 998–1011, 2009.
[30]
Y. S. Lim, K. A. Kim, J. O. Jung et al., “Modulation of cytokeratin expression during in vitro cultivation of human hepatic stellate cells: evidence of transdifferentiation from epithelial to mesenchymal phenotype,” Histochemistry and Cell Biology, vol. 118, no. 2, pp. 127–136, 2002.
[31]
K. Fujio, R. P. Evarts, Z. Hu, E. R. Marsden, and S. S. Thorgeirsson, “Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat,” Laboratory Investigation, vol. 70, no. 4, pp. 511–516, 1994.
[32]
J. Dudas, T. Mansuroglu, D. Batusic, B. Saile, and G. Ramadori, “Thy-1 is an in vivo and in vitro marker of liver myofibroblasts,” Cell and Tissue Research, vol. 329, no. 3, pp. 503–514, 2007.
[33]
J. Dudas, T. Mansuroglu, D. Batusic, and G. Ramadori, “Thy-1 is expressed in myofibroblasts but not found in hepatic stellate cells following liver injury,” Histochemistry and cell biology, vol. 131, no. 1, pp. 115–127, 2009.
[34]
T. Knittel, D. Kobold, B. Salle et al., “Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential,” Gastroenterology, vol. 117, no. 5, pp. 1205–1221, 1999.
[35]
D. Kobold, A. Grundmann, F. Piscaglia et al., “Expression of reelin in hepatic stellate cells and during hepatic tissue repair: a novel marker for the differentiation of HSC from other liver myofibroblasts,” Journal of Hepatology, vol. 36, no. 5, pp. 607–613, 2002.
[36]
W. Timens and W. A. Kamps, “Hemopoiesis in human fetal and embryonic liver,” Microscopy Research and Technique, vol. 39, pp. 387–397, 1997.
[37]
P. S. Amenta and D. Harrison, “Expression and potential role of the extracellular matrix in hepatic ontogenesis: a review,” Microscopy Research and Technique, vol. 39, pp. 372–386, 1997.
[38]
R. Weinstein, M. A. Riordan, K. Wenc, S. Kreczko, M. Zhou, and N. Dainiak, “Dual role of fibronectin in hematopoietic differentiation,” Blood, vol. 73, no. 1, pp. 111–116, 1989.
[39]
T. Yokota, K. Oritani, H. Mitsui et al., “Growth-supporting activities of fibronectin on hematopoietic stem/progenitor cells in vitro and in vivo: structural requirement for fibronectin activities of CS1 and cell-binding domains,” Blood, vol. 91, no. 9, pp. 3263–3272, 1998.
[40]
D. Tamiolakis, I. Venizelos, S. Nikolaidou, and T. Jivanakis, “Normal development of fetal hepatic haematopoiesis during the second trimester of gestation is upregulated by fibronectin expression in the stromal cells of the portal triads,” Revista Espanola de Enfermedades Digestivas, vol. 99, no. 10, pp. 576–580, 2007.
[41]
P. Charbord, J. P. Rémy-Martin, E. Tamayo, G. Bernard, A. Keating, and B. Péault, “Analysis of the microenvironment necessary for engraftment: role of the vascular smooth muscle-like stromal cells,” Journal of Hematotherapy and Stem Cell Research, vol. 9, no. 6, pp. 935–943, 2000.
[42]
J. E. Dennis and P. Charbord, “Origin and differentiation of human and murine stroma,” Stem Cells, vol. 20, no. 3, pp. 205–214, 2002.
[43]
L. Sensebe, M. Deschaseaux, J. Li, P. Herve, and P. Charbord, “The broad spectrum of cytokine gene expression by myoid cells from the human marrow microenvironment,” Stem Cells, vol. 15, no. 2, pp. 133–143, 1997.
[44]
J. Gerhart, B. Bast, C. Neely et al., “MyoD-positive myoblasts are present in mature fetal organs lacking skeletal muscle,” Journal of Cell Biology, vol. 155, no. 4, pp. 381–391, 2001.
[45]
S. N. Gornostaeva, A. A. Rzhaninova, and D. V. Gol'dstein, “Myogenesis in hemopoietic tissue mesenchymal stem cell culture,” Bulletin of Experimental Biology and Medicine, vol. 141, no. 4, pp. 493–499, 2006.
[46]
O. N. Sheveleva, O. V. Payushina, M. N. Kozhevnikova, N. N. Butorina, and V. I. Starostin, “Spontaneous and induced myogenesis in cell cultures from rat fetal liver,” Cell and Tissue Biology, vol. 5, pp. 551–559, 2011.
[47]
J. Henningsen, K. T. G. Rigbolt, B. Blagoev, B. K. Pedersen, and I. Kratchmarova, “Dynamics of the skeletal muscle secretome during myoblast differentiation,” Molecular and Cellular Proteomics, vol. 9, no. 11, pp. 2482–2496, 2010.
[48]
E. Barbera-Guillem, J. M. Arrue, J. Ballesteros, and F. Vidal-Vanaclocha, “Structural changes in endothelial cells of developing rat liver in the transition from fetal to postnatal life,” Journal of Ultrastructure and Molecular Structure Research, vol. 97, no. 1–3, pp. 197–206, 1986.
[49]
A. Couvelard, J. Y. Scoazec, M. C. Dauge, A. F. Bringuier, F. Potet, and G. Feldmann, “Structural and functional differentiation of sinusoidal endothelial cells during liver organogenesis in humans,” Blood, vol. 87, no. 11, pp. 4568–4580, 1996.
[50]
K. M. Schweitzer, A. M. Dr?ger, P. Van Der Valk et al., “Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues,” American Journal of Pathology, vol. 148, no. 1, pp. 165–175, 1996.
[51]
O. Wittig, J. Paez-Cortez, and J. E. Cardier, “Liver sinusoidal endothelial cells promote B lymphopoiesis from primitive hematopoietic cells,” Stem Cells and Development, vol. 19, no. 3, pp. 341–349, 2010.
[52]
I. Sawitza, C. Kordes, S. Reister, and D. H?ussinger, “The niche of stellate cells within rat liver,” Hepatology, vol. 50, no. 5, pp. 1617–1624, 2009.
[53]
H. Iwasaki, F. Arai, Y. Kubota, M. Dahl, and T. Suda, “Endothelial protein C receptor-expressing hematopoietic stem cells reside in the perisinusoidal niche in fetal liver,” Blood, vol. 116, no. 4, pp. 544–553, 2010.
[54]
Q. Li and L. F. Congoto, “Bovine fetal-liver stromal cells support erythroid colony formation: enhancement by insulin-like growth factor II,” Experimental Hematology, vol. 23, no. 1, pp. 66–73, 1995.
[55]
O. Ohneda and V. L. Bautch, “Murine endothelial cells support fetal liver erythropoiesis and myelopoiesis via distinct interactions,” British Journal of Haematology, vol. 98, no. 4, pp. 798–808, 1997.
[56]
M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006.
[57]
A. J. Friedenstein, U. F. Gorskaja, and N. N. Kulagina, “Fibroblast precursors in normal and irradiated mouse hematopoietic organs,” Experimental Hematology, vol. 4, no. 5, pp. 267–274, 1976.
[58]
L. da Silva Meirelles, P. C. Chagastelles, and N. B. Nardi, “Mesenchymal stem cells reside in virtually all post-natal organs and tissues,” Journal of Cell Science, vol. 119, no. 11, pp. 2204–2213, 2006.
[59]
S. R. M. Versele, R. L. Van Den Heuvel, G. E. R. Schoeters, and O. L. J. Vanderborght, “Proliferation activity of stromal stem cells (CFU-f) from hemopoietic organs of pre- and postnatal mice,” Radiation Research, vol. 111, no. 2, pp. 185–191, 1987.
[60]
P. V. Guillot, C. Gotherstrom, J. Chan, H. Kurata, and N. M. Fisk, “Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC,” Stem Cells, vol. 25, no. 3, pp. 646–654, 2007.
[61]
M. N. Kozhevnikova, A. S. Mikaelyan, and V. I. Starostin, “Molecular-genetic and immunophenotypic analysis of antigen profile and osteogenic and adipogenic potentials of mesenchymal stromal cells from fetal liver and adult bone marrow in rats,” Cell and Tissue Biology, vol. 3, no. 3, pp. 222–235, 2009.
[62]
P. S. In 't Anker, W. A. Noort, S. A. Scherjon et al., “Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential,” Haematologica, vol. 88, no. 8, pp. 845–852, 2003.
[63]
P. V. Guillot, C. De Bari, F. Dell'Accio, H. Kurata, J. Polak, and N. M. Fisk, “Comparative osteogenic transcription profiling of various fetal and adult mesenchymal stem cell sources,” Differentiation, vol. 76, no. 9, pp. 946–957, 2008.
[64]
X. Y. Wang, Y. Lan, W. Y. He et al., “Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos,” Blood, vol. 111, no. 4, pp. 2436–2443, 2008.
[65]
R. L. Van Den Heuvel, S. R. M. Versele, G. E. R. Schoeters, and O. L. J. Vanderborght, “Stromal stem cells (CFU-f) in yolk sac, liver, spleen and bone marrow of pre- and postnatal mice,” British Journal of Haematology, vol. 66, no. 1, pp. 15–20, 1987.
[66]
O. V. Payushina, E. I. Bueverova, G. P. Satdykova, V. I. Starostin, E. I. Domaratskaya, and N. G. Khrushchov, “Comparative investigation of mesenchymal stem cells isolated from the bone marrow and fetal liver of mouse and rat,” Biology Bulletin, vol. 31, no. 6, pp. 546–551, 2004.
[67]
O. V. Payushina, N. N. Butorina, T. M. Nikonova, M. N. Kozhevnikova, O. N. Sheveleva, and V. I. Starostin, “Clonal growth and differentiation of mesenchymal stromal cells from rat liver at different stages of embryogenesis,” Cell and Tissue Biology, vol. 6, pp. 12–19, 2012.
[68]
F. P. Russo, M. R. Alison, B. W. Bigger et al., “The bone marrow functionally contributes to liver fibrosis,” Gastroenterology, vol. 130, no. 6, pp. 1807–1821, 2006.
[69]
A. S. Krupnick, K. R. Balsara, D. Kreisel et al., “Fetal liver as a source of autologous progenitor cells for perinatal tissue engineering,” Tissue Engineering, vol. 10, no. 5-6, pp. 723–735, 2004.
[70]
N. Van Overstraeten-Schl?gel, Y. Beguin, and A. Gothot, “Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells,” European Journal of Haematology, vol. 76, no. 6, pp. 488–493, 2006.
[71]
M. K. Majumdar, M. A. Thiede, J. D. Mosca, M. Moorman, and S. L. Gerson, “Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells,” Journal of Cellular Physiology, vol. 176, pp. 57–66, 1998.
[72]
W. Wagner, C. Roderburg, F. Wein et al., “Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors,” Stem Cells, vol. 25, no. 10, pp. 2638–2647, 2007.
[73]
Y. Hu, L. Y. Zhang, G. J. Ma, X. Y. Jiang, and C. H. Zhao, “Phenotypical and biological characteristics of human fetal marrow and liver mesenchymal stem cells,” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 9, pp. 289–293, 2001.
[74]
J. Chagraoui, A. Lepage-Noll, A. Anjo, G. Uzan, and P. Charbord, “Fetal liver stroma consists of cells in epithelial-to-mesenchymal transition,” Blood, vol. 101, no. 8, pp. 2973–2982, 2003.
[75]
H. Zhang, Z. Miao, Z. He, Y. Yang, Y. Wang, and M. Feng, “The existence of epithelial-to-mesenchymal cells with the ability to support hematopoiesis in human fetal liver,” Cell Biology International, vol. 29, no. 3, pp. 213–219, 2005.
[76]
B. Li, Y. W. Zheng, Y. Sano, and H. Taniguchi, “Evidence for mesenchymal-epithelial transition associated with mouse hepatic stem cell differentiation,” PLoS ONE, vol. 6, no. 2, article e17092, 2011.
[77]
M. Lambropoulou, D. Tamiolakis, I. Venizelos et al., “Induction of hepatic haematopoiesis with fibronectin expression by EMT stromal cells during the second trimester of development,” Clinical and Experimental Medicine, vol. 7, pp. 115–121, 2007.
[78]
K. S. Ishikawa, T. Masui, K. Ishikawa, and N. Shiojiri, “Immunolocalization of hepatocyte growth factor and its receptor (c-Met) during mouse liver development,” Histochemistry and Cell Biology, vol. 116, no. 5, pp. 453–462, 2001.
[79]
E. Schmelzer, L. Zhang, A. Bruce et al., “Human hepatic stem cells from fetal and postnatal donors,” Journal of Experimental Medicine, vol. 204, no. 8, pp. 1973–1987, 2007.
[80]
A. Xiong, T. W. Austin, E. Lagasse et al., “Isolation of human fetal liver progenitors and their enhanced proliferation by three-dimensional coculture with endothelial cells,” Tissue Engineering A, vol. 14, no. 6, pp. 995–1006, 2008.
[81]
H. Nagai, K. Terada, G. Watanabe et al., “Differentiation of liver epithelial (stem-like) cells into hepatocytes induced by coculture with hepatic stellate cells,” Biochemical and Biophysical Research Communications, vol. 293, no. 5, pp. 1420–1425, 2002.
[82]
V. Jodon de Villeroché and D. Brouty-Boyé, “Establishment and characterization of atypical fibroblasts from human adult liver contributing to hepatocyte cord-like arrangement,” Cell Biology International, vol. 32, no. 6, pp. 605–614, 2008.
[83]
L. Libbrecht, D. Cassiman, V. Desmet, and T. Roskams, “The correlation between portal myofibroblasts and development of intrahepatic bile ducts and arterial branches in human liver,” Liver, vol. 22, no. 3, pp. 252–258, 2002.
[84]
T. Kinoshita, T. Sekiguchi, M. J. Xu et al., “Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 13, pp. 7265–7270, 1999.